健康社会决定因素与代谢功能障碍相关脂肪性肝病患病率及严重程度的关联:系统综述与荟萃分析
该系统综述与荟萃分析检索2010年1月至2024年5月MEDLINE、Embase和Cochrane数据库,纳入18项美国成人研究共547,634名受试者,评估健康社会决定因素对MASLD患病率及严重程度的影响。高饮食质量与MASLD患病率(汇总OR 0.76,P<0.01)及MASH相关进展期纤维化/肝硬化患病率(汇总OR 0.74,P<0.01)的关联最为一致,其他社会决定因素关联不一致。
要点
- 高饮食质量与MASLD患病率降低相关(汇总OR 0.76,P<0.01)。
- 高饮食质量与MASH相关进展期纤维化/肝硬化患病率降低相关(汇总OR 0.74,P<0.01)。
- 低收入与临床结局风险的关联在3/9项研究中显著,其他社会决定因素关联不一致。
核心结论
- 饮食质量是MASLD中与疾病患病率和严重程度关联最一致的健康社会决定因素,其他社会决定因素显示不一致的关联。
- 需要采用共识性、经验证的工具进行前瞻性评估,以明确特定社会决定因素对异质性患者人群MASLD负担的影响,从而为公共卫生干预提供信息。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南检索MEDLINE、Embase和Cochrane数据库。
- 纳入2010年1月至2024年5月发表的美国成人定量研究,评估除种族/民族以外的健康社会决定因素。
- 共纳入18项研究,包含来自11个独特队列的547,634名受试者。
- 9项研究评估MASLD患病率,3项评估MASH患病率,6项评估MASH相关进展期纤维化/肝硬化患病率,9项评估临床结局。
主要发现
- 高饮食质量与MASLD患病率的汇总OR为0.76(P<0.01)。
- 高饮食质量与MASH相关进展期纤维化/肝硬化患病率的汇总OR为0.74(P<0.01)。
- 低收入与临床结局风险的关联在3/9项研究中显著。
- 其他健康社会决定因素与MASLD患病率及严重程度的关联不一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要采用共识性、经验证的工具进行前瞻性评估,以明确特定社会决定因素对异质性患者人群MASLD负担的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Social determinants of health (SDOHs) affect disease risk and severity leading to health disparities. SDOH impacting metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence and severity are poorly characterized, and results are conflicting. The aim of this systematic review and meta-analysis was to assess the impact of individual SDOH factors on MASLD burden for adults in the United States. METHODS: We searched MEDLINE, Embase, and Cochrane databases per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies from January 2010 to May 2024 were included. Quantitative studies of adults in the United States that evaluated SDOH beyond race/ethnicity were included. Outcomes included prevalence of MASLD, metabolic dysfunction-associated steatohepatitis (MASH), MASH-associated advanced fibrosis or cirrhosis, and clinical outcomes. RESULTS: We identified 18 studies comprising 547,634 total subjects from 11 unique cohorts. Nine studies evaluated MASLD prevalence, 3 MASH prevalence, 6 MASH-associated advanced fibrosis/cirrhosis prevalence, and 9 clinical outcomes. High-diet quality was the most consistent SDOH factor associated with both MASLD and MASH-associated advanced fibrosis/cirrhosis prevalence (summarized odds ratio of 0.76, P < 0.01, and 0.74, P < 0.01, respectively). Lower income was most consistently associated with risk of clinical outcomes (significant in 3/9 studies). DISCUSSION: Diet quality was the most consistent SDOH associated with disease prevalence and severity in MASLD, with other SDOH showing inconsistent associations. Prospective assessments using consensus, validated tools to assess the impact of specific SDOH on MASLD burden in heterogenous patient populations are needed to inform public health interventions.
引用
- Abu-Rumaileh M, Dhoop S, Pace J, et al. Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2025. PMID: 40094308. doi:10.14309/ajg.0000000000003421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。